Cargando…
Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome
BACKGROUND: Metabolic syndrome (MetS) is associated with an increased risk of the development of atherosclerotic cardiovascular disease (CVD). Interleukin-18 (IL-18), which is a pleiotropic proinflammatory cytokine with important regulatory functions in the innate immune response system, plays a cru...
Autores principales: | Yamaoka-Tojo, Minako, Tojo, Taiki, Wakaume, Kazuki, Kameda, Ryo, Nemoto, Shinji, Takahira, Naonobu, Masuda, Takashi, Izumi, Tohru |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038890/ https://www.ncbi.nlm.nih.gov/pubmed/21251304 http://dx.doi.org/10.1186/1743-7075-8-3 |
Ejemplares similares
-
Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease
por: Yamaoka-Tojo, Minako, et al.
Publicado: (2010) -
Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis
por: Namba, Sayaka, et al.
Publicado: (2015) -
Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide
por: Kitasato, Lisa, et al.
Publicado: (2012) -
Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
por: Yamaoka-Tojo, Minako, et al.
Publicado: (2009) -
Molecular Mechanisms Underlying the Progression of Aortic Valve Stenosis: Bioinformatic Analysis of Signal Pathways and Hub Genes
por: Tojo, Taiki, et al.
Publicado: (2023)